Clinical Trials Logo

Clinical Trial Summary

Acetylsalicylic acid (Aspirin, ASA) is the most widely prescribed drug used in primary and secondary prevention of cardiovascular disease. However, aspirin resistance has been described, mostly in cardiac patients and is an independent predictive factor for a poor survival. Two frequent conditions in patients with cardiovascular diseases, diabetes and hypercholesterolemia, are also considered as risk factors for aspirin resistance. Among patients with peripheral arterial disease, those with critical limb ischemia have the worst cardiovascular prognosis. At one year, 23% are dead, 25% have a major cardiovascular event and 25% have a major amputation (which can be combined). Aspirin resistance is poorly studied in these patients, and to our knowledge no study has been made to assess the prognosis value of aspirin resistance on cardiovascular outcomes in critical limb ischaemia patients.

Hospitalized critical limb ischaemia patients will be tested for aspirin resistance using the bed-side point of care VerifyNow®, and will be followed during one year, including death, fatal and non-fatal acute coronary syndromes, cardiac decompensation, stroke, and major amputation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01104441
Study type Observational
Source University Hospital, Limoges
Contact
Status Completed
Phase
Start date April 2010
Completion date April 2016

See also
  Status Clinical Trial Phase
Completed NCT01432652 - The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery N/A
Completed NCT00948987 - Mechanism Based Resistance to Aspirin Phase 1
Unknown status NCT01935193 - Aspirin Resistance Reversibility in Diabetic Patients Phase 4
Not yet recruiting NCT01547039 - Platelet Reactivity and MES During CEA N/A
Completed NCT01159639 - Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting Phase 4
Completed NCT00792272 - Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients N/A
Completed NCT00466154 - The Effect of Serum LDL Lowering on Aspirin Resistance N/A